Haemonetics Sets Date for 2nd Quarter Fiscal 2017 Earnings Release: November 7, 2016
Get Alerts HAE Hot Sheet
Join SI Premium – FREE
BRAINTREE, Mass., Oct. 13, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced that the Company will publish fiscal year 2017 second quarter financial results at 6:00am Eastern Time on Monday, November 7, 2016. The Company will hold a webcast conference call with investors and analysts to discuss and answer questions about the results at 8:00am Eastern Time on November 7, 2016.
Webcast Link: http://edge.media-server.com/m/p/wcn22ipf
Webcast replay will be available from November 7, 2016 after 10:00am Eastern Time.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit http://www.haemonetics.com.
INVESTOR CONTACT: Gerry Gould, VP-Investor Relations(781) 356-9402[email protected]
MEDIA CONTACT:Sandra Jesse, Executive VP(781) 356-9253[email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/haemonetics-sets-date-for-2nd-quarter-fiscal-2017-earnings-release-november-7-2016-300344714.html
SOURCE Haemonetics Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Benchmark on Take-Two's (TTWO) GTV 6 Release: 'we anticipate that the game will not be released within the fiscal year and expect it to launch in fiscal 2026 instead'
- American International Group (AIG) PT Raised to $89 at Piper Sandler
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!